Predictions
GFT Technologies AG
Start price
Target price
Perf. (%)
€39.45
06.12.21
06.12.21
€43.50
06.12.22
06.12.22
-12.29%
07.12.22
07.12.22
Could be worthwhile Investment >10% per year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€5.22
05.12.21
05.12.21
€2.70
05.12.22
05.12.22
-44.67%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€3.87
05.12.21
05.12.21
€1.90
05.12.22
05.12.22
-24.28%
16.03.22
16.03.22
Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Baozun Inc ADR
Start price
Target price
Perf. (%)
€11.75
05.12.21
05.12.21
€4.00
05.12.22
05.12.22
-40.26%
16.03.22
16.03.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Radius Health Inc.
Start price
Target price
Perf. (%)
€13.05
05.12.21
05.12.21
-
05.12.22
05.12.22
-48.66%
11.12.21
11.12.21
Risky Investment
MacroGenics Inc.
Start price
Target price
Perf. (%)
€14.88
05.12.21
05.12.21
-
05.12.22
05.12.22
0.47%
12.12.21
12.12.21
Risky Investment
Group 1 Automotive
Start price
Target price
Perf. (%)
€179.00
05.12.21
05.12.21
-
05.12.22
05.12.22
0.56%
06.12.22
06.12.22
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€147.98
05.12.21
05.12.21
-
05.12.22
05.12.22
-23.17%
07.01.22
07.01.22
Could be worthwhile Investment >10% per year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.42
03.12.21
03.12.21
-
03.12.22
03.12.22
7.50%
11.12.21
11.12.21
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.62
03.12.21
03.12.21
-
03.12.22
03.12.22
0.84%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.28
02.12.21
02.12.21
-
02.12.22
02.12.22
-0.61%
11.12.21
11.12.21
Risky Investment
Prodways Group
Start price
Target price
Perf. (%)
€2.92
01.12.21
01.12.21
€3.20
01.12.22
01.12.22
35.27%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Lannett Co. Inc.
Start price
Target price
Perf. (%)
€5.88
01.12.21
01.12.21
-
01.12.22
01.12.22
-61.58%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€14.52
01.12.21
01.12.21
-
01.12.22
01.12.22
-11.23%
11.12.21
11.12.21
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.96
01.12.21
01.12.21
€6.00
01.12.22
01.12.22
-2.70%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
BioXcel Therapeutics Inc
Start price
Target price
Perf. (%)
€17.00
01.12.21
01.12.21
-
01.12.22
01.12.22
16.71%
12.12.21
12.12.21
Risky Investment
Krystal Biotech
Start price
Target price
Perf. (%)
€66.00
01.12.21
01.12.21
€50.00
31.12.23
31.12.23
16.67%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€25.50
01.12.21
01.12.21
€28.00
01.12.22
01.12.22
-31.92%
20.05.22
20.05.22
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Ardelyx Inc.
Start price
Target price
Perf. (%)
€0.99
30.11.21
30.11.21
€1.00
30.11.22
30.11.22
36.36%
11.12.21
11.12.21
Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
Focus Home Interactive SAS
Start price
Target price
Perf. (%)
€38.95
30.11.21
30.11.21
€50.00
30.11.22
30.11.22
18.49%
01.12.22
01.12.22
Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.25
30.11.21
30.11.21
-
30.11.22
30.11.22
-17.83%
12.12.21
12.12.21
Probably not worthwhile Investment